Choosing which EGFR inhibitor to use in second line treatment of mCRC patients At Annual Meeting GI 2016

Choosing which EGFR inhibitor to use in second line treatment of mCRC patients At Annual Meeting GI 2016

264 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Alan P. Venook, MD of University of California San Francisco discusses which EGFR inhibitor to use in second line treatment of mCRC patients at ASCO GI 2016
Up Next Autoplay